nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0257	0.0383	CcSEcCtD
Hyoscyamine—Cocaine—SCN5A—dilated cardiomyopathy	0.0256	0.655	CrCbGaD
Hyoscyamine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0146	0.0217	CcSEcCtD
Hyoscyamine—Blindness—Lisinopril—dilated cardiomyopathy	0.0145	0.0216	CcSEcCtD
Hyoscyamine—Ipratropium bromide—SLC22A5—dilated cardiomyopathy	0.0135	0.345	CrCbGaD
Hyoscyamine—Ataxia—Spironolactone—dilated cardiomyopathy	0.0134	0.02	CcSEcCtD
Hyoscyamine—Heartburn—Lisinopril—dilated cardiomyopathy	0.0117	0.0174	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0114	0.017	CcSEcCtD
Hyoscyamine—Laryngitis—Lisinopril—dilated cardiomyopathy	0.0111	0.0166	CcSEcCtD
Hyoscyamine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.011	0.0164	CcSEcCtD
Hyoscyamine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0105	0.0156	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00888	0.0133	CcSEcCtD
Hyoscyamine—Swelling—Furosemide—dilated cardiomyopathy	0.0088	0.0131	CcSEcCtD
Hyoscyamine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00854	0.0127	CcSEcCtD
Hyoscyamine—Thirst—Furosemide—dilated cardiomyopathy	0.00816	0.0122	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00802	0.012	CcSEcCtD
Hyoscyamine—Lethargy—Furosemide—dilated cardiomyopathy	0.00792	0.0118	CcSEcCtD
Hyoscyamine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00779	0.0116	CcSEcCtD
Hyoscyamine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00758	0.0113	CcSEcCtD
Hyoscyamine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00753	0.0112	CcSEcCtD
Hyoscyamine—Irritability—Furosemide—dilated cardiomyopathy	0.00741	0.0111	CcSEcCtD
Hyoscyamine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00738	0.011	CcSEcCtD
Hyoscyamine—Dehydration—Furosemide—dilated cardiomyopathy	0.00722	0.0108	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00714	0.0107	CcSEcCtD
Hyoscyamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00707	0.0106	CcSEcCtD
Hyoscyamine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00706	0.0105	CcSEcCtD
Hyoscyamine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00703	0.0105	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00701	0.0105	CcSEcCtD
Hyoscyamine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00675	0.0101	CcSEcCtD
Hyoscyamine—Eczema—Lisinopril—dilated cardiomyopathy	0.00648	0.00967	CcSEcCtD
Hyoscyamine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00639	0.00954	CcSEcCtD
Hyoscyamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00623	0.0093	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00615	0.00917	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00605	0.00903	CcSEcCtD
Hyoscyamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00598	0.00893	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00597	0.00891	CcSEcCtD
Hyoscyamine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00585	0.00873	CcSEcCtD
Hyoscyamine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00582	0.00869	CcSEcCtD
Hyoscyamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00578	0.00862	CcSEcCtD
Hyoscyamine—Sweating—Furosemide—dilated cardiomyopathy	0.00574	0.00856	CcSEcCtD
Hyoscyamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00557	0.00831	CcSEcCtD
Hyoscyamine—Irritability—Lisinopril—dilated cardiomyopathy	0.00556	0.0083	CcSEcCtD
Hyoscyamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00554	0.00827	CcSEcCtD
Hyoscyamine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00554	0.00827	CcSEcCtD
Hyoscyamine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00548	0.00817	CcSEcCtD
Hyoscyamine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00542	0.00808	CcSEcCtD
Hyoscyamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00517	0.00771	CcSEcCtD
Hyoscyamine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00496	0.0074	CcSEcCtD
Hyoscyamine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0049	0.00732	CcSEcCtD
Hyoscyamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0048	0.00716	CcSEcCtD
Hyoscyamine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0048	0.00716	CcSEcCtD
Hyoscyamine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00471	0.00703	CcSEcCtD
Hyoscyamine—Erythema—Furosemide—dilated cardiomyopathy	0.00467	0.00698	CcSEcCtD
Hyoscyamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00464	0.00692	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00464	0.00692	CcSEcCtD
Hyoscyamine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00458	0.00683	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00454	0.00678	CcSEcCtD
Hyoscyamine—Depression—Lisinopril—dilated cardiomyopathy	0.00448	0.00668	CcSEcCtD
Hyoscyamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00446	0.00665	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00442	0.0066	CcSEcCtD
Hyoscyamine—Rash—Spironolactone—dilated cardiomyopathy	0.00442	0.0066	CcSEcCtD
Hyoscyamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00442	0.00659	CcSEcCtD
Hyoscyamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00441	0.00658	CcSEcCtD
Hyoscyamine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0044	0.00657	CcSEcCtD
Hyoscyamine—Headache—Spironolactone—dilated cardiomyopathy	0.00439	0.00656	CcSEcCtD
Hyoscyamine—Sweating—Lisinopril—dilated cardiomyopathy	0.0043	0.00642	CcSEcCtD
Hyoscyamine—Agitation—Furosemide—dilated cardiomyopathy	0.0043	0.00641	CcSEcCtD
Hyoscyamine—Vertigo—Furosemide—dilated cardiomyopathy	0.0042	0.00627	CcSEcCtD
Hyoscyamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00417	0.00622	CcSEcCtD
Hyoscyamine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0041	0.00612	CcSEcCtD
Hyoscyamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00401	0.00598	CcSEcCtD
Hyoscyamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00389	0.00581	CcSEcCtD
Hyoscyamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00385	0.00574	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00382	0.00569	CcSEcCtD
Hyoscyamine—Shock—Furosemide—dilated cardiomyopathy	0.00375	0.0056	CcSEcCtD
Hyoscyamine—Flushing—Lisinopril—dilated cardiomyopathy	0.00374	0.00558	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00369	0.0055	CcSEcCtD
Hyoscyamine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.0036	0.00537	CcSEcCtD
Hyoscyamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00357	0.00532	CcSEcCtD
Hyoscyamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00353	0.00527	CcSEcCtD
Hyoscyamine—Erythema—Lisinopril—dilated cardiomyopathy	0.00351	0.00523	CcSEcCtD
Hyoscyamine—Tension—Lisinopril—dilated cardiomyopathy	0.00344	0.00514	CcSEcCtD
Hyoscyamine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00343	0.00513	CcSEcCtD
Hyoscyamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00341	0.00508	CcSEcCtD
Hyoscyamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00339	0.00506	CcSEcCtD
Hyoscyamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00331	0.00493	CcSEcCtD
Hyoscyamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00329	0.00491	CcSEcCtD
Hyoscyamine—Constipation—Furosemide—dilated cardiomyopathy	0.00326	0.00487	CcSEcCtD
Hyoscyamine—Pain—Furosemide—dilated cardiomyopathy	0.00326	0.00487	CcSEcCtD
Hyoscyamine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00321	0.00478	CcSEcCtD
Hyoscyamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00315	0.0047	CcSEcCtD
Hyoscyamine—Syncope—Lisinopril—dilated cardiomyopathy	0.00315	0.00469	CcSEcCtD
Hyoscyamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00314	0.00469	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00312	0.00466	CcSEcCtD
Hyoscyamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.0031	0.00463	CcSEcCtD
Hyoscyamine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00308	0.0046	CcSEcCtD
Hyoscyamine—Urticaria—Furosemide—dilated cardiomyopathy	0.00303	0.00452	CcSEcCtD
Hyoscyamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00302	0.0045	CcSEcCtD
Hyoscyamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00302	0.0045	CcSEcCtD
Hyoscyamine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00299	0.00446	CcSEcCtD
Hyoscyamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00298	0.00444	CcSEcCtD
Hyoscyamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00292	0.00436	CcSEcCtD
Hyoscyamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00289	0.00431	CcSEcCtD
Hyoscyamine—Oedema—Lisinopril—dilated cardiomyopathy	0.00286	0.00427	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00286	0.00427	CcSEcCtD
Hyoscyamine—Shock—Lisinopril—dilated cardiomyopathy	0.00282	0.0042	CcSEcCtD
Hyoscyamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00281	0.0042	CcSEcCtD
Hyoscyamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00279	0.00417	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00277	0.00413	CcSEcCtD
Hyoscyamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00274	0.00409	CcSEcCtD
Hyoscyamine—Pruritus—Furosemide—dilated cardiomyopathy	0.0027	0.00403	CcSEcCtD
Hyoscyamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00268	0.00399	CcSEcCtD
Hyoscyamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00261	0.0039	CcSEcCtD
Hyoscyamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00259	0.00386	CcSEcCtD
Hyoscyamine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00255	0.00381	CcSEcCtD
Hyoscyamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00255	0.0038	CcSEcCtD
Hyoscyamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00252	0.00377	CcSEcCtD
Hyoscyamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00252	0.00376	CcSEcCtD
Hyoscyamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00247	0.00368	CcSEcCtD
Hyoscyamine—Constipation—Lisinopril—dilated cardiomyopathy	0.00245	0.00365	CcSEcCtD
Hyoscyamine—Pain—Lisinopril—dilated cardiomyopathy	0.00245	0.00365	CcSEcCtD
Hyoscyamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00243	0.00362	CcSEcCtD
Hyoscyamine—Rash—Furosemide—dilated cardiomyopathy	0.00241	0.00359	CcSEcCtD
Hyoscyamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.0024	0.00359	CcSEcCtD
Hyoscyamine—Headache—Furosemide—dilated cardiomyopathy	0.00239	0.00357	CcSEcCtD
Hyoscyamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00236	0.00352	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00234	0.00349	CcSEcCtD
Hyoscyamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00227	0.00339	CcSEcCtD
Hyoscyamine—Nausea—Furosemide—dilated cardiomyopathy	0.00227	0.00338	CcSEcCtD
Hyoscyamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00226	0.00338	CcSEcCtD
Hyoscyamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00226	0.00338	CcSEcCtD
Hyoscyamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00211	0.00315	CcSEcCtD
Hyoscyamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00205	0.00307	CcSEcCtD
Hyoscyamine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00203	0.00302	CcSEcCtD
Hyoscyamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00196	0.00292	CcSEcCtD
Hyoscyamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00189	0.00283	CcSEcCtD
Hyoscyamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00182	0.00272	CcSEcCtD
Hyoscyamine—CHRM4—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00181	0.00623	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00181	0.00621	CbGpPWpGaD
Hyoscyamine—Rash—Lisinopril—dilated cardiomyopathy	0.00181	0.00269	CcSEcCtD
Hyoscyamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0018	0.00269	CcSEcCtD
Hyoscyamine—Headache—Lisinopril—dilated cardiomyopathy	0.00179	0.00268	CcSEcCtD
Hyoscyamine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00179	0.00615	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00172	0.00593	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00172	0.00593	CbGpPWpGaD
Hyoscyamine—Nausea—Lisinopril—dilated cardiomyopathy	0.0017	0.00254	CcSEcCtD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0016	0.00551	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0016	0.0055	CbGpPWpGaD
Hyoscyamine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00151	0.00518	CbGpPWpGaD
Hyoscyamine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.0015	0.00517	CbGpPWpGaD
Hyoscyamine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00149	0.00512	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00149	0.00512	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00144	0.00495	CbGpPWpGaD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00141	0.00483	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00137	0.00471	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00137	0.00471	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00127	0.00438	CbGpPWpGaD
Hyoscyamine—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00124	0.00428	CbGpPWpGaD
Hyoscyamine—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00124	0.00426	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00123	0.00424	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00123	0.00423	CbGpPWpGaD
Hyoscyamine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00123	0.00422	CbGpPWpGaD
Hyoscyamine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00122	0.0042	CbGpPWpGaD
Hyoscyamine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00122	0.00419	CbGpPWpGaD
Hyoscyamine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00121	0.00415	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00118	0.00407	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00117	0.00401	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00115	0.00395	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00115	0.00395	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00108	0.00371	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00108	0.0037	CbGpPWpGaD
Hyoscyamine—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00107	0.00369	CbGpPWpGaD
Hyoscyamine—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00107	0.00368	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00107	0.00367	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00107	0.00366	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00105	0.00362	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00104	0.00359	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00104	0.00359	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00103	0.00353	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.001	0.00345	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.001	0.00344	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.001	0.00344	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00099	0.0034	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000972	0.00334	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000971	0.00334	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000968	0.00333	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00096	0.0033	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000959	0.0033	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000957	0.00329	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000948	0.00326	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000945	0.00325	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00094	0.00323	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000936	0.00322	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000933	0.00321	CbGpPWpGaD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000932	0.00321	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000924	0.00318	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000924	0.00318	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000922	0.00317	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000922	0.00317	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000913	0.00314	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000913	0.00314	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000859	0.00296	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000857	0.00295	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000848	0.00292	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000832	0.00286	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00083	0.00285	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00083	0.00285	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000827	0.00284	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000822	0.00283	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000819	0.00282	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000803	0.00276	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000787	0.00271	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000785	0.0027	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000777	0.00267	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000762	0.00262	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000761	0.00262	CbGpPWpGaD
Hyoscyamine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000755	0.0026	CbGpPWpGaD
Hyoscyamine—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000753	0.00259	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000742	0.00255	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000711	0.00244	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000709	0.00244	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000704	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000704	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000702	0.00241	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000702	0.00241	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000702	0.00241	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000695	0.00239	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000695	0.00239	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00068	0.00234	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000676	0.00232	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000674	0.00232	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000673	0.00232	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000672	0.00231	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000666	0.00229	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000654	0.00225	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000652	0.00224	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000646	0.00222	CbGpPWpGaD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000639	0.0022	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000639	0.0022	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000634	0.00218	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000632	0.00217	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000629	0.00216	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000627	0.00215	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000626	0.00215	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000621	0.00214	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000621	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00059	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00059	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000578	0.00199	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000565	0.00194	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000549	0.00189	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000541	0.00186	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00054	0.00186	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000536	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000536	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000534	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000531	0.00183	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000514	0.00177	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000512	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000507	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0005	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000499	0.00171	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000498	0.00171	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000494	0.0017	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000482	0.00166	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000469	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000467	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000454	0.00156	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000431	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00043	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00043	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000426	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000412	0.00142	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000398	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000398	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000397	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000397	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000393	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000393	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000391	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000391	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000381	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00038	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000376	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00037	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000369	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000365	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000361	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000361	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00036	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00036	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000358	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000357	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000357	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000357	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000356	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000354	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000336	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000335	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000334	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000332	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000325	0.00112	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000324	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000322	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000321	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00032	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000319	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000317	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000317	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000306	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000305	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000303	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000302	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000294	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00029	0.000998	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00029	0.000997	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000289	0.000995	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000286	0.000985	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000285	0.00098	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000278	0.000955	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000277	0.000952	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000274	0.000943	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000264	0.000906	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000263	0.000903	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00026	0.000895	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000243	0.000837	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00024	0.000826	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00024	0.000824	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000237	0.000816	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000231	0.000794	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000225	0.000775	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000225	0.000772	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000222	0.000765	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000215	0.00074	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000215	0.000738	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000213	0.000734	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000213	0.000734	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000213	0.000731	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000213	0.000731	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000213	0.000731	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000211	0.000724	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000211	0.000724	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000205	0.000704	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000204	0.000701	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000202	0.000694	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000201	0.000692	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000198	0.000682	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000198	0.000682	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000198	0.00068	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000196	0.000673	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000195	0.000672	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000195	0.00067	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000193	0.000664	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000192	0.000661	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000192	0.000659	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00019	0.000652	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000179	0.000616	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000171	0.000589	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000164	0.000564	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000164	0.000562	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000162	0.000557	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000157	0.00054	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000156	0.000535	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000155	0.000534	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000154	0.000528	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000153	0.000526	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000138	0.000474	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000138	0.000473	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000136	0.000466	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000135	0.000465	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000134	0.00046	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000134	0.00046	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000133	0.000459	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000132	0.000454	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000121	0.000416	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00012	0.000414	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000119	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000119	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000115	0.000397	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000115	0.000396	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000114	0.000392	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.3e-05	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.27e-05	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.18e-05	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	8.15e-05	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.01e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.99e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.91e-05	0.000272	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.5e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.48e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.43e-05	0.000187	CbGpPWpGaD
